Related references
Note: Only part of the references are listed.Worldwide prevalence of Lynch syndrome in patients with colorectal cancer: Systematic review and meta-analysis
Nadine Abu-Ghazaleh et al.
GENETICS IN MEDICINE (2022)
Heterogeneity of Mismatch Repair Status and Microsatellite Instability between Primary Tumour and Metastasis and Its Implications for Immunotherapy in Colorectal Cancers
Camille Evrard et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Mismatch Repair-Deficient Colorectal Cancer: Building on Checkpoint Blockade
Zhaohui Jin et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Current Microsatellite Instability Testing in Management of Colorectal Cancer
Belinda L. Sun
CLINICAL COLORECTAL CANCER (2021)
Should you repeat mismatch repair testing in cases of tumour recurrence? An evaluation of repeat mismatch repair testing by the use of immunohistochemistry in recurrent tumours of the gastrointestinal and gynaecological tracts
John J. Aird et al.
HISTOPATHOLOGY (2020)
Screening for Lynch Syndrome by Immunohistochemistry of Mismatch Repair Proteins Significance of Indeterminate Result and Correlation With Mutational Studies
Venetia R. Sarode et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2019)
Comparison of Mismatch Repair Status Between Primary and Matched Metastatic Sites in Patients With Colorectal Cancer
Wen-Zhuo He et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database
Pal Moller et al.
GUT (2018)
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer
Michael J. Overman et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Two-stain immunohistochemical screening for Lynch syndrome in colorectal cancer may fail to detect mismatch repair deficiency
Rachel Pearlman et al.
MODERN PATHOLOGY (2018)
Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database
Pal Moller et al.
GUT (2017)
Can Microsatellite Status of Colorectal Cancer Be Reliably Assessed after Neoadjuvant Therapy?
Jennifer B. Goldstein et al.
CLINICAL CANCER RESEARCH (2017)
Molecular genetics of microsatellite-unstable colorectal cancer for pathologists
Wei Chen et al.
DIAGNOSTIC PATHOLOGY (2017)
Comparison of the Mismatch Repair System between Primary and Metastatic Colorectal Cancers Using Immunohistochemistry
Jiyoon Jung et al.
JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE (2017)
Mismatch repair deficiency concordance between primary colorectal cancer and corresponding metastasis
Sigurdis Haraldsdottir et al.
FAMILIAL CANCER (2016)
Discordant Mismatch Repair Protein Immunoreactivity in Lynch Syndrome-Associated Neoplasms A Recommendation for Screening Synchronous/Metachronous Neoplasms
Rachel M. Roth et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2016)
Mismatch repair deficiency testing in clinical practice
Natalia Buza et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2016)
Microsatellite Instability Testing and Its Role in the Management of Colorectal Cancer
Hisato Kawakami et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2015)
How reliable is immunohistochemical staining for DNA mismatch repair proteins performed after neoadjuvant chemoradiation?
Alex Vilkin et al.
HUMAN PATHOLOGY (2014)
The genetic basis of Lynch syndrome and its implications for clinical practice and risk management
Stephanie A. Cohen et al.
APPLICATION OF CLINICAL GENETICS (2014)
Cancer Risks for MLH1 and MSH2 Mutation Carriers
James G. Dowty et al.
HUMAN MUTATION (2013)
Challenging cases encountered in colorectal cancer screening for Lynch syndrome reveal novel findings: nucleolar MSH6 staining and impact of prior chemoradiation therapy
Oana M. Radu et al.
HUMAN PATHOLOGY (2011)
Cancer Risks Associated With Germline Mutations in MLH1, MSH2, and MSH6 Genes in Lynch Syndrome
Valerie Bonadona et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant Therapy
Frank A. Sinicrope et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Neoadjuvant Therapy Induces Loss of MSH6 Expression in Colorectal Carcinoma
Fei Bao et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
Interobserver variability in the evaluation of mismatch repair protein immunostaining
Louise Klarskov et al.
HUMAN PATHOLOGY (2010)
Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications
H. T. Lynch et al.
CLINICAL GENETICS (2009)
Feasibility of Screening for Lynch Syndrome Among Patients With Colorectal Cancer
Heather Hampel et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome - Part I. The utility of immunohistochemistry
Jinru Shia
JOURNAL OF MOLECULAR DIAGNOSTICS (2008)
Share Paper
